CFA
MRK icon

Camarda Financial Advisors’s Merck MRK Stock Holding History

Camarda Financial Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,119
Closed -$346K – 115
2025
Q3 		$346K Sell
4,119
-3,835
-48% -$316K 0.13% 98
2025
Q2 		$630K Sell
7,954
-7,742
-49% -$615K 0.25% 82
2025
Q1 		$1.41M Sell
15,696
-124
-0.8% -$11.6K 0.64% 46
2024
Q4 		$1.57M Sell
15,820
-264
-2% -$27.2K 0.59% 51
2024
Q3 		$1.83M Hold
16,084
– – 0.68% 51
2024
Q2 		$1.99M Hold
16,084
– – 0.78% 39
2024
Q1 		$2.12M Sell
16,084
-187
-1% -$23K 0.86% 34
2023
Q4 		$1.77M Sell
16,271
-178
-1% -$18.5K 0.76% 41
2023
Q3 		$1.69M Sell
16,449
-53
-0.3% -$5.71K 1.09% 27
2023
Q2 		$1.9M Buy
16,502
+1
+0% +$114 0.95% 24
2023
Q1 		$1.76M Sell
16,501
-206
-1% -$22.2K 1.32% 16
2022
Q4 		$1.85M Buy
16,707
+366
+2% +$37.4K 1.87% 19
2022
Q3 		$1.41M Hold
16,341
– – 1.65% 15
2022
Q2 		$1.49M Sell
16,341
-180
-1% -$16K 1.48% 21
2022
Q1 		$1.36M Sell
16,521
-665
-4% -$52.4K 0.65% 42
2021
Q4 		$1.32M Buy
17,186
+1,065
+7% +$84.8K 0.75% 17
2021
Q3 		$1.21M Sell
16,121
-6,837
-30% -$520K 0.82% 12
2021
Q2 		$1.78M Sell
22,958
-1,102
-5% -$82K 1.1% 18
2021
Q1 		$1.77M Buy
24,060
+7,165
+42% +$529K 1.27% 19
2020
Q4 		$1.32M Buy
16,895
+13
+0.1% +$994 1.11% 19
2020
Q3 		$1.34M Hold
16,882
– – 1.62% 15
2020
Q2 		$1.25M Sell
16,882
-1,258
-7% -$94.7K 1.74% 16
2020
Q1 		$1.33M Buy
18,140
+1,258
+7% +$98.9K 6.73% 1
2019
Q4 		$1.47M Hold
16,882
– – 3.11% 10
2019
Q3 		$1.36M Sell
16,882
-201
-1% -$16.1K 3.16% 20
2019
Q2 		$1.37M Sell
17,083
-212
-1% -$16.2K 2.68% 20
2019
Q1 		$1.37M Buy
17,295
+706
+4% +$52.8K 2.62% 17
2018
Q4 		$1.21M Sell
16,589
-241
-1% -$17K 1.44% 22
2018
Q3 		$1.14M Buy
16,830
+163
+1% +$10.4K 1.29% 16
2018
Q2 		$965K Hold
16,667
– – 1.01% 23
2018
Q1 		$866K Hold
16,667
– – 0.9% 31
2017
Q4 		$895K Sell
16,667
-578
-3% -$32K 1.07% 28
2017
Q3 		$1.05M Sell
17,245
-258
-1% -$15.6K 1.13% 27
2017
Q2 		$1.07M Sell
17,503
-1,750
-9% -$107K 1.14% 26
2017
Q1 		$1.17M Sell
19,253
-5,826
-23% -$353K 1.14% 28
2016
Q4 		$1.41M Sell
25,079
-2,545
-9% -$149K 0.96% 45
2016
Q3 		$1.65M Buy
27,624
+673
+2% +$39.4K 1% 28
2016
Q2 		$1.48M Buy
26,951
+657
+2% +$35K 0.94% 35
2016
Q1 		$1.33M Buy
26,294
+3,593
+16% +$176K 0.83% 39
2015
Q4 		$1.14M Buy
22,701
+399
+2% +$20.1K 0.7% 52
2015
Q3 		$1.05M Sell
22,302
-386
-2% -$20.5K 0.65% 54
2015
Q2 		$1.23M Sell
22,688
-3,910
-15% -$219K 0.69% 50
2015
Q1 		$1.46M Sell
26,598
-206
-0.8% -$11.7K 0.81% 37
2014
Q4 		$1.45M Buy
26,804
+1,763
+7% +$98.2K 0.92% 39
2014
Q3 		$1.42M Sell
25,041
-1,698
-6% -$95.3K 0.98% 40
2014
Q2 		$1.48M Buy
26,739
+3,928
+17% +$214K 1.01% 39
2014
Q1 		$1.24M Buy
22,811
+20,502
+888% +$1.06M 0.95% 39
2013
Q4 		$110K Sell
2,309
-560
-20% -$25.6K 0.09% 73
2013
Q3 		$130K Buy
2,869
+1,116
+64% +$51K 0.17% 51
2013
Q2 		$78K Buy
+1,753
New +$78.3K 0.07% 98

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Camarda Financial Advisors's MRK Position: Q4 2025 in Review

Camarda Financial Advisors sold out of Merck (MRK) in Q4 2025, closing a stake of 4,119 shares — an estimated $346K sold.

Camarda Financial Advisors first reported a position in MRK in Q2 2013 and held it in 50 quarters. The position peaked at $2.12M in Q1 2024. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Camarda Financial Advisors reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Camarda Financial Advisors sold 4,119 Merck shares in Q4 2025, an estimated $346K.
  • Camarda Financial Advisors first reported a position in Merck in Q2 2013 and held it in 50 quarters.
  • Camarda Financial Advisors's Merck position peaked at $2.12M in Q1 2024.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Camarda Financial Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.